Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Revance Therapeutics Inc.

    NASDAQ: RVNC · Real-Time Price · USD
    3.65
    0.00 (0.00%)
    At close: Feb 05, 2025, 3:59 PM

    Revance Therapeutics Revenue

    Revance Therapeutics reported an annual revenue of $234.04M, reflecting a 76.55% growth. For the quarter ending September 30, 2024, Revance Therapeutics generated $59.88M in revenue.
    Revenue (ttm)
    $234.04M
    Revenue Growth
    76.55%
    Price / Sales Ratio
    3.18
    Revenue / Employee
    $392.03K
    Employees
    597
    Market Cap
    381.02M

    Revenue Chart

    Revenue History

    Fiscal Year End Revenue % Change
    Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

    Add to Watchlist